Company History

Elixir was founded in 1999 based on seminal discoveries of founders Cynthia Kenyon (UCSF) and Lenny Guarente (MIT) who studied the genetics and molecular biology of aging in laboratory animals. They discovered that modulating the evolutionary-conserved anti-aging genes and pathways in mammals not only increased lifespan, but also promoted weight loss and increased insulin sensitivity. Accordingly, the Company's understanding of these pathways has been converted into a platform for the discovery, development of and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity.
The Company has been financed by premier venture groups in the healthcare industry including MPM Capital, Oxford Biosciences Partners, ARCH Venture Partners and Physic Ventures.

[ back to top ]